Skip to main content
. 2021 Dec 14;12(12):1158. doi: 10.1038/s41419-021-04451-8

Fig. 6. Knockdown of ITGB1 reversed the tumor-promoting effect of ALDH3B2 overexpression.

Fig. 6

A The knockdown efficiency of ITGB1 was determined by western blot in RBE and QBC939 cell lines. B Western blot analysis of the efficiency of ITGB1 knockdown in ALDH3B2-overexpressing RBE (left) and QBC939 (right) cell lines. C CCK-8 assays were performed to identify the alteration in cell proliferation ability after ITGB1 knockdown in ALDH3B2-overexpressing RBE (upper) and QBC939 (lower) cells. Knockdown of ITGB1 reversed the promoting effect of ALDH3B2 overexpression on the proliferation ability of RBE and QBC939 cells. D Transwell assays without matrigel were performed to evaluate the migration ability of RBE and QBC939 cells after ITGB1 knockdown in ALDH3B2-overexpressing RBE (upper) and QBC939 (lower) cells. Knockdown of ITGB1 reversed the promoting effect of ALDH3B2 overexpression on the migration ability of RBE and QBC939 cells. E Transwell assays with matrigel were performed to evaluate the invasion ability of RBE and QBC939 cells after ITGB1 knockdown in ALDH3B2-overexpressing RBE (upper) and QBC939 (lower) cells. Knockdown of ITGB1 reversed the promoting effect of ALDH3B2 overexpression on the invasion ability of RBE and QBC939 cells. F EMT biomarkers, including E-cadherin, N-cadherin, and snail, were detected by western blot in ALDH3B2-overexpressing RBE cells (left) and QBC939 cells (right) with or without ITGB1 knockdown. EMT-promoting effect of ALDH3B2 overexpression in RBE cells and QBC939 cells was reversed by knocking down the expression of ITGB1. G Western blot analysis of the expression of ITGB1 and the phosphorylation level of its downstream signaling pathway in ALDH3B2-overexpressing RBE cells (left) and QBC939 cells (right) with or without ITGB1 knockdown. Knocking down the expression of ITGB1 partially reversed the effect of ALDH3B2 overexpression.